John Bearden McAdory
CIK: 0002137500
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCY
ONCOLYTICS BIOTECH INC
Officer
Discretionary Trading P&L
Holdings
About McAdory John Bearden
McAdory John Bearden (SEC CIK 0002137500) files insider reports with the SEC as Chief Operating Officer of ONCOLYTICS BIOTECH INC (ONCY).
Signal8 holds 2 ownership filings by McAdory John Bearden (1 Form 3, 1 Form 4), filed on Jun 3, 2026. Those filings report 1 transaction, the latest on Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McAdory John Bearden's filings is in SAN DIEGO, CA.
Recent filings by McAdory John Bearden
- Jun 1, 2026: Grant or award of ONCY derivative securities (Form 4, code A).
Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)
- Pisano Wayne, Director
- RIGBY JONATHAN, Director
- Holtham Angela, Director
- Parsons James T., Director
- Look Kirk, Chief Financial Officer
- Aromando Andrew, Chief Business Officer